也是在昨天，辉瑞公司宣布放弃其正在实验中的抗肥胖药物。
Also yesterday, Pfizer said it was giving up on an experimental anti-obesity drug.
而且，没有MCH而被饲养的小鼠保持瘦的体型并能够生育——这也可能使其成为大受欢迎的候选抗肥胖药物。
And mice bred without MCH remain lean - and fertile - which has made it a popular candidate for anti-obesity drugs as well.
现在，我们可以考虑开发减弱fto基因活性的药物，用作抗肥胖药。
We can now think about developing drugs that turn down the activity of the FTO gene as potential anti-obesity pills.
现在，我们可以考虑开发减弱fto基因活性的药物，用作抗肥胖药。
We can now think about developing drugs that turn down the activity of the FTO gene as potential anti-obesity pills.
应用推荐